Cero Therapeutics Holdings, Inc.股价重挫13.52% 市值跌69.83万美元

市场透视2025-04-25

北京时间2025年04月25日21时31分，Cero Therapeutics Holdings, Inc.（CERO.us）股票出现波动，股价急速下跌13.52%。截至发稿，该股报0.960美元/股，成交量43.048万股，换手率8.00%，振幅4.94%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.30百万美元，每股收益-3.44美元，毛利-1.16百万美元，市盈率-0.02...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530139766?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-25 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2530139766","market":"us","top_or_hot":-1,"title":"Cero Therapeutics Holdings, Inc.股价重挫13.52% 市值跌69.83万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月25日21时31分，Cero Therapeutics Holdings, Inc.（CERO.us）股票出现波动，股价急速下跌13.52%。截至发稿，该股报0.960美元/股，成交量43.048万股，换手率8.00%，振幅4.94%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.30百万美元，每股收益-3.44美元，毛利-1.16百万美元，市盈率-0.02...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213148a6c81d11&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cero Therapeutics Holdings, Inc.股价重挫13.52% 市值跌69.83万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCero Therapeutics Holdings, Inc.股价重挫13.52% 市值跌69.83万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-25 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213148a6c81d11&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月25日21时31分，Cero Therapeutics Holdings, Inc.（CERO.us）股票出现波动，股价急速下跌13.52%。截至发稿，该股报0.960美元/股，成交量43.048万股，换手率8.00%，振幅4.94%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.30百万美元，每股收益-3.44美元，毛利-1.16百万美元，市盈率-0.02...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213148a6c81d11&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CERO","symbol_name":"CERo Therapeutics Holdings, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213148a6c81d11&s=b","article_id":"2530139766","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213148a6c81d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2530139766","pubTimestamp":1745587908,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月25日21时31分，Cero Therapeutics Holdings, Inc.股票出现波动，股价急速下跌13.52%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。消息层面，截至21时31分，《D. Boral Capital：维持CERo Therapeutics Hldgs评级》资讯为影响Cero Therapeutics Holdings, Inc.的重要信息。该信息摘要如下：D.Boral Capital：维持CERo Therapeutics Hldgs评级，由买入调整至买入评级,目标价由11.00美元调整至11.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CERO":"CERo Therapeutics Holdings, Inc.","BK4007":"制药","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Cero Therapeutics Holdings, Inc. Stock Plunges 13.52%, Market Value Falls $698,300","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CERO":0.9,"LENZ":1},"content_text":"北京时间2025年04月25日21时31分，Cero Therapeutics Holdings, Inc.（CERO.us）股票出现波动，股价急速下跌13.52%。截至发稿，该股报0.960美元/股，成交量43.048万股，换手率8.00%，振幅4.94%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-8.30百万美元，每股收益-3.44美元，毛利-1.16百万美元，市盈率-0.02倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Azitra Inc、Geovax Labs, Inc.、Lixte Biotechnology Holdings, Inc.涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为185.75%、41.21%、40.38%，振幅较大的相关个股有Azitra Inc、Polyrizon Ltd.、Acrivon Therapeutics, Inc.，振幅分别为12.97%、8.57%、8.22%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。其专有的T细胞工程方法使其能够将先天免疫和适应性免疫的某些理想特征整合到单一的治疗结构中，旨在利用人体的全部免疫功能，来实现优化的癌症治疗。消息层面，截至21时31分，《D. Boral Capital：维持CERo Therapeutics Hldgs评级》资讯为影响Cero Therapeutics Holdings, Inc.的重要信息。该信息摘要如下：D.Boral Capital：维持CERo Therapeutics Hldgs(CERO.US)评级，由买入调整至买入评级,目标价由11.00美元调整至11.00美元。CERo Therapeutics(CERO.US)公司简介：CERo Therapeutics Holdings Inc是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。其专有的T细胞工程方法使其能够将先天免疫和适应性免疫的某些理想特征整合到单一的治疗结构中，旨在利用人体的全部免疫功能，来实现优化的癌症治疗。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530139766","isCrawlerRequest":true}